
Growth Inhibition by Interferon Beta and Gamma of MDA 886Ln Monolayer Cells and Multicellular Tumor SpheroidsA Differentiation Therapy Model for Squamous Cell Carcinoma
Peter G. Sacks, PhD;
Tomas Racz, MD;
Stimson P. Schantz, MD;
Michael G. Rosenblum, PhD
Arch Otolaryngol Head Neck Surg. 1994;120(11):1267-1272.
Abstract
 |  |
Objective The ability of interferon beta (IFN-β) and interferon gamma (IFN- ) to modulate growth and differentiation of squamous carcinoma was studied.
Design Two squamous carcinoma models (MDA 886Ln monolayer cells and multicellular tumor spheroids [MTSs], an in vitro system with three-dimensional in vivo—like structure) were used. Effects of interferons were examined with growth and differentiation assays.
Results In 5-day monolayer growth assays, both interferons (IFNs) exhibited dose-dependent growth inhibition between 0 and 104 U/mL; IFN- was more inhibitory than IFN-β (inhibitory concentration for 50% inhibition of 9 and 900 U/mL for IFN- and IFN-β, respectively). Multicellular tumor spheroid growth was examined by sizing MTSs over a 9-day growth period. Multicellular tumor spheroids were resistant to IFN-β with exposures of up to 50 000 U/mL. Similarly, MTSs were resistant to IFN- for the first several days, with growth inhibition becoming evident between days 7 to 9 of culture. As a marker of differentiation, transglutaminase activity was quantified after 5 days of treatment. Both IFNs induced increased transglutaminase activity in monolayer cells: IFN-β was twice as effective as IFN- . In contrast, 5-day treated MTSs showed no induction although their endogenous activity was higher. Flow cytometric analysis of monolayer cells for induction of class I and II major histocompatibility complex showed that both IFNs induced class I antigens but only IFN- could induce class II.
Conclusions With their three-dimensional architecture, MTSs were more resistant to IFN-induced growth inhibition and differentiation induction than monolayer cells. Thus, mode of growth (monolayer vs MTS) is an important factor in responsiveness to IFN treatment; this suggests that MTSs may produce information that is more relevant to in vivo usage than monolayer cells.
(Arch Otolaryngol Head Neck Surg. 1994;120:1267-1272)
Author Affiliations
From the Memorial Sloan-Kettering Cancer Center, New York, NY (Drs Sacks and Schantz); R-Klinika Felsozoldmali, Budapest, Hungary (Dr Racz); and the University of Texas M. D. Anderson Cancer Center, Houston (Dr Rosenblum).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Interferon Gamma Enhances Lymphokine-Activated Killer Cell Adhesion but Not Lysis of Head and Neck Squamous Cell Carcinoma
Scher et al.
Arch Otolaryngol Head Neck Surg 1995;121:1271-1275.
ABSTRACT
|